| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | +1.3% |
| Cost of Revenue | $181K | — | +16.0% |
| Gross Profit | $1.1M | — | -0.8% |
| R&D Expense | $455K | — | +10.4% |
| SG&A Expense | $168K | — | +11.2% |
| Operating Income | $79K | — | -28.3% |
| Pre-tax Income | $84K | — | -29.2% |
| Income Tax | $0 | — | — |
| Net Income | $84K | — | -29.2% |
| EPS (Basic) | $0.01 | — | +0.0% |
| EPS (Diluted) | $0.01 | — | +0.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.4M | +21.9% | -10.8% |
| Accounts Receivable | $890K | +3.1% | +23.2% |
| Current Assets | $2.3M | +6.9% | -3.9% |
| Total Assets | $3.0M | -0.1% | -18.3% |
| Current Liabilities | $497K | -8.7% | +11.1% |
| Total Liabilities | $497K | -8.7% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $299K | — | +37.2% |
| Capital Expenditures | $325 | — | -92.5% |
| Investing Cash Flow | -$30K | — | +68.9% |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | $298K | — | +39.8% |
| +11.1% |
| Stockholders' Equity | $2.5M | +1.9% | -22.4% |